Our Services
Medical Information
Helpful Resources
Published on: 7/15/2026
What is the average survival rate for stage 4 prostate cancer?
Stage 4 prostate cancer survival rates vary widely depending on where the cancer has spread, the patient's age, overall health, and response to treatment. On average, the 5-year relative survival rate for metastatic (stage 4) prostate cancer is approximately 30-35%, which is significantly lower than earlier stages, where survival rates often exceed 95%. Factors influencing prognosis include whether the cancer has spread to nearby lymph nodes, bones, or distant organs, as well as the effectiveness of therapies such as hormone therapy, chemotherapy, and newer targeted treatments.
If you or a loved one are experiencing symptoms that concern you—such as difficulty urinating, blood in urine, bone pain, or unexplained fatigue—getting clarity early can make a meaningful difference. Understanding your symptoms is the first step toward informed conversations with your doctor and timely care. Take a free, instant, online symptom check to better understand what may be going on and confidently navigate your next steps.
Reviewed for medical accuracy: 07/14/2026
Important Next Steps
Not seeing your question? No worries.
Submit your own QuestionExplanation
Stage 4 prostate cancer means that the cancer has spread beyond the prostate to other parts of the body, like bones or lymph nodes. This stage is also known as metastatic prostate cancer. If you're experiencing concerning symptoms, consider using a free AI symptom checker to help identify potential health issues and determine when to seek medical care.
Survival Rates:
According to the research, the 10-year survival rate for metastatic prostate cancer is significantly lower than for earlier stages.
Patients with stage 4 prostate cancer have varied survival outcomes, depending on many factors, including the extent of the spread and the patient's overall health.
Research Insights:
One study indicated that survival rates can be affected by the location and extent of metastasis. For example, patients with cancer that has spread to bones may have different outcomes compared to those with cancer spread to other organs.
Another study highlighted that newer treatments and therapies might improve survival rates, but these advances are still developing.
In summary, while stage 4 prostate cancer presents more challenges, ongoing research and treatment advancements provide hope for improved outcomes.
(References)
Tangen CM, Faulkner JR, Crawford ED, Thompson IM, Hirano D, Eisenberger M, & Hussain M. (2003). Ten-year survival in patients with metastatic prostate cancer. Clinical prostate cancer, 15046683.
Hsiao W, Moses KA, Goodman M, Jani AB, Rossi PJ, & Master VA. (2010). Stage IV prostate cancer: survival differences in clinical T4, .... The Journal of urology, 20620410.
Siegel DA, O'Neil ME, Richards TB, Dowling NF, & Weir HK. (2020). Prostate Cancer Incidence and Survival, by Stage .... MMWR. Morbidity and mortality weekly report, 33056955.
Tell your friends about us.
We would love to help them too.
For First Time Users
What is Ubie’s Doctor’s Note?
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.